NCT01384786

Brief Summary

Patients with hyperthyroidism and/or goiter are evaluated with blood samples and scintiscan before they are treated with radioiodine for their thyroid disease. Because the investigators do not get a histologically/final diagnosis the investigators want to make sure, that the patients treated do not have a thyroid cancer when treated. The investigators have found that thyroid cancer is not overlooked.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,474

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2004

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2005

Completed
6 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 29, 2011

Completed
Last Updated

June 29, 2011

Status Verified

June 1, 2011

First QC Date

June 28, 2011

Last Update Submit

June 28, 2011

Conditions

Hyperthyreosis and GoiterThyroid Cancer

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Radioiodine treated patients

You may qualify if:

  • all patients treated with radioiodine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

herlev Hospital

Copenhagen, Denmark

Location

MeSH Terms

Conditions

GoiterThyroid Neoplasms

Condition Hierarchy (Ancestors)

Thyroid DiseasesEndocrine System DiseasesEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck Neoplasms

Study Officials

  • Anders Vej-Hansen

    Herlev Hospital, Copenhagen, Denmark

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 28, 2011

First Posted

June 29, 2011

Study Start

October 1, 2004

Study Completion

July 1, 2005

Last Updated

June 29, 2011

Record last verified: 2011-06

Locations

DK(1)